share_log

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

週一，Livent、Amgen 和其他一些大股走低
Benzinga Real-time News ·  2022/09/12 11:11

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today's session.

美國股市走高，道瓊恩斯指數周一上漲超過250點。以下是今日盤中錄得漲幅的一些大盤股。

  • DICE Therapeutics, Inc. (NASDAQ:DICE) fell 19.6% to $18.20. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
  • Entrada Therapeutics, Inc. (NASDAQ:TRDA) dropped 11.4% to $13.21. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • ShiftPixy, Inc. (NASDAQ:PIXY) fell 9.8% to $31.06 after gaining 11% on Friday.
  • Azure Power Global Limited (NYSE:AZRE) dropped 9.3% to $5.32.
  • Immatics N.V. (NASDAQ:IMTX) fell 9% to $11.69.
  • Microvast Holdings, Inc. (NASDAQ:MVST) declined 8.3% to $2.3197.
  • Construction Partners, Inc. (NASDAQ:ROAD) fell 7.8% to $28.00.
  • Forge Global Holdings, Inc. (NYSE:FRGE) dropped 7.8% to $4.04.
  • Burning Rock Biotech Limited (NASDAQ:BNR) declined 7.2% to $3.33.
  • Humacyte, Inc. (NASDAQ:HUMA) fell 7.1% to $4.19. Humacyte recently filed for mixed-securities shelf offering of up to $300 million.
  • Couchbase, Inc. (NASDAQ:BASE) dipped 7.1% to $14.49. The company, last week, posted upbeat quarterly results.
  • Livent Corporation (NYSE:LTHM) fell 5.8% to $32.46 after Verticle Research downgraded the stock from Buy to Hold and announced a $35 price target.
  • Amgen Inc. (NASDAQ:AMGN) dropped 3.7% to $238.44 following FDA approval of Bristol Myers Squibb's plaque psoriasis drug Sotyktu, which showed superior efficacy to Amgen's Otezla.
  • Dice治療公司納斯達克(DICE：DICE)跌19.6%，報18.20美元。上週，Stifel以買入評級和37美元的目標價對該股展開了報道。
  • Entrada治療公司納斯達克(Tmall：TRDA)下跌11.4%，至13.21美元。Entrada治療公司上個月公佈第二季度每股虧損0.74美元。
  • ShiftPixy，Inc.納斯達克(Sequoia Capital：PIXY)下跌9.8%，至31.06美元，上週五上漲11%。
  • 蔚藍電力環球有限公司(紐約證券交易所股票代碼：AZRE)下跌9.3%，至5.32美元。
  • Immatics N.V.納斯達克(Tmall：IMTX)下跌9%，至11.69美元。
  • Microvast控股公司納斯達克(Sequoia Capital：MVST)下跌8.3%，至2.3197美元。
  • 建築合作夥伴公司(納斯達克：ROAD)下跌7.8%，至28.00美元。
  • 福奇全球控股有限公司(紐約證券交易所代碼：FRGE)下跌7.8%，至4.04美元。
  • 燃石醫學有限公司納斯達克(Sequoia Capital：BNR)下跌7.2%，至3.33美元。
  • Humacyte，Inc.納斯達克(Tmall：HUMA)跌7.1%，報4.19美元。Humacyte最近申請了高達3億美元的混合證券貨架發售申請。
  • Couchbase，Inc.(納斯達克：基礎)下跌7.1%，至14.49美元。上週，該公司公佈了樂觀的季度業績。
  • 利文特公司(紐約證券交易所代碼：LTHM)股價下跌5.8%，至32.46美元，此前Verticle Research將該股評級從買入下調至持有，並宣佈了35美元的目標價。
  • 安進。納斯達克公司股價下跌3.7%，至238.44美元，此前美國食品和藥物管理局批准百時美施貴寶公司的斑塊型牛皮癬藥物Sotyktu，該藥的療效優於安進公司的奧特茲拉。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論